Login

NOVELION THERAPEUTICS INC. 4/A SEC Filings

Filed On Filing
11 Apr 2017 Form 4/A: Corrigan Mark, Director

Granted 9,600 Stock Option (Right to Buy)

03 Feb 2017 Form 4/A: Smith Sandford D, Director

Received 456 shares by exercise or conversion

07 Jun 2013 Form 4/A: Aryeh Jason, Director

Disposed of 34 Short Put Option (obligation to buy) (Open Market Sale) ($1.36K)

19 Jul 2012 Form 4/A: Thomas John C, Director

Granted 11,000 Phantom Stock

11 Jul 2012 Form 4/A: Clarke C Boyd, Former Director

Acquired 20,000 shares (Gift)

26 May 2009 Form 4/A: Hao Yong, Vice President, Development

Holds 6,591 shares of Common Stock

16 Apr 2009 Form 4/A: Nb Public Equity K/S, 10% owner and 2 others

Bought 27,835 shares ($64.6K)

02 Aug 2005 Form 4/A: Butchofsky Robert, VP Marketing & Sales Planning

Sold 7,100 shares ($61.7K)

10 Mar 2005 Form 4/A: Clarke C Boyd, Director

Granted 7,500 Phantom Stock

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support